White House Pushes FDA on Hydroxychloroquine Again

“White House trade adviser Peter Navarro is leading a Trump administration effort to demand the Food and Drug Administration reverse course and grant a second emergency authorization for the antimalarial drug hydroxychloroquine to treat covid-19, the disease caused by the coronavirus,” the Washington Post reports.

“Navarro, armed with a controversial new study that he says shows the drug’s effectiveness, is being cheered on by President Trump, who has long touted the drug as a ‘game changer’ and even used himself as a possible preventive measure.”